Famotidine clinical trial shows COVID-19 symptom reduction

Authors: Dagnia Zeidlickis, Vice President, Communications | zeidlick@cshl.edu | 516-367-8455 A high dose of famotidine, commonly known as Pepcid®, was found to have beneficial effects in adult patients with coronavirus disease 2019 (COVID-19), according…[...]